UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Gallbladder Carcinoma, the Difficulty of Early Detection: A Case Report

Curēus (Palo Alto, CA), 2016-02

2016

Volltextzugriff (PDF)

The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis

The Journal of experimental medicine, 2007-07, Vol.204 (7), p.1559-1569

2007

Volltextzugriff (PDF)

Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer

The New England journal of medicine, 2018-04, Vol.378 (15), p.1408-1418

2018

Volltextzugriff (PDF)

Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors

Medical physics (Lancaster), 2003-02, Vol.30 (2), p.199-203

2003

Volltextzugriff (PDF)

AE37: a novel T-cell-eliciting vaccine for breast cancer

Expert opinion on biological therapy, 2011-11, Vol.11 (11), p.1543-1550

2011

Volltextzugriff (PDF)

Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neck

Cancer, 2001-02, Vol.91 (3), p.548-554

2001

Volltextzugriff (PDF)

The significance of circulating epithelial cells in Breast Cancer patients by a novel negative selection method

Breast cancer research and treatment, 2008-09, Vol.111 (2), p.355-364

2008

Volltextzugriff (PDF)

Interleukin 2 gene transfer prevents NKG2D suppression and enhances antitumor efficacy in combination with cisplatin for head and neck squamous cell cancer

Cancer research (Chicago, Ill.), 2002-07, Vol.62 (14), p.4023

2002

Volltextzugriff (PDF)

New recurrent balanced translocations in acute myeloid leukemia and myelodysplastic syndromes: Cancer and leukemia group B 8461

Genes chromosomes & cancer, 2013-04, Vol.52 (4), p.385-401

2013

Volltextzugriff (PDF)

Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib

Annals of oncology, 2019-12, Vol.30 (12), p.1959-1968

2019

Volltextzugriff (PDF)

Phase I Trial of All-Trans Retinoic Acid in Patients with Treated Head and Neck Squamous Carcinoma

Clinical cancer research, 2000-03, Vol.6 (3), p.847

2000

Volltextzugriff (PDF)

Prospective validation of a pharmacologically based dosing scheme for the cis-diamminedichloroplatinum(II) analogue diamminecyclobutanedicarboxylatoplatinum

Cancer research (Chicago, Ill.), 1985-12, Vol.45 (12), p.6502-6506

1985

Volltextzugriff (PDF)

Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors

Clinical cancer research, 1998-03, Vol.4 (3), p.629-634

1998

Volltextzugriff (PDF)

Neoadjuvant chemoradiation to convert locally advanced pancreatic body adenocarcinoma to resectable disease

Clinical advances in hematology & oncology, 2003-12, Vol.1 (12), p.741

2003

Volltextzugriff (PDF)

Phase I Trial of Granulocyte—Macrophage Colony-Stimulating Factor Plus High-Dose Cyclophosphamide Given Every 2 Weeks: a Cancer and Leukemia Group B Study

JNCI : Journal of the National Cancer Institute, 1993-08, Vol.85 (16), p.1319-1326

1993

Volltextzugriff (PDF)

A limited sampling strategy for cyclophosphamide pharmacokinetics

Cancer research (Chicago, Ill.), 1989-06, Vol.49 (11), p.3129-3133

1989

Volltextzugriff (PDF)

Phase I clinical and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered as a five-day continuous infusion

Cancer research (Chicago, Ill.), 1987-01, Vol.47 (2), p.617-623

1987

Volltextzugriff (PDF)

Gram-negative multidrug-resistant organism colonization in a US military healthcare facility in Iraq

Infection control and hospital epidemiology, 2011-06, Vol.32 (6), p.545-552

2011

Volltextzugriff (PDF)

Phase I trial using adaptive control dosing of hexamethylene bisacetamide (NSC 95580)

Cancer research (Chicago, Ill.), 1989-06, Vol.49 (12), p.3436

1989

Volltextzugriff (PDF)

Human pharmacokinetics, excretion, and metabolism of the anthracycline antibiotic menogaril (7-OMEN, NSC 269148) and their correlation with clinical toxicities

Cancer research (Chicago, Ill.), 1986-03, Vol.46 (3), p.1513-1520

1986

Volltextzugriff (PDF)

Biomarker correlation to clinical response in phase I/II trials of the adjuvant breast cancer vaccine neuvax (nelipepimut-S or E75)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.TPS3126-TPS3126

2013

Volltextzugriff (PDF)

Phase I study and pharmacokinetics of menogaril (NSC 269148) in patients with hepatic dysfunction

Cancer research (Chicago, Ill.), 1987-11, Vol.47 (22), p.6104-6110

1987

Volltextzugriff (PDF)

Abstract LB-413: Circulating regulatory T cells (CD4+CD25high CD127low) decrease in breast cancer patients after vaccination with a modified HER-2/ neu HLA class II peptide (AE37) vaccine

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.LB-413-LB-413

2011

Volltextzugriff (PDF)

Abstract LB-414: Comparison of in vitro and in vivo immunologic responses in a prospective, randomized, single-blinded phase II trial evaluating the HER-2/ neu peptide vaccines GP2 and AE37 in breast cancer patients

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.LB-414-LB-414

2011

Volltextzugriff (PDF)

Combination nonviral interleukin 2 gene therapy and external-beam radiation therapy for head and neck cancer

Archives of otolaryngology--head & neck surgery, 2003-06, Vol.129 (6), p.618

2003

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(40)
Berichte
(1)

Sprache

Englisch
(41)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Humans
(32)
Life Sciences & Biomedicine
(32)
Science & Technology
(32)
Biological And Medical Sciences
(21)
Female
(21)
Medical Sciences
(21)
Oncology
(21)
Middle Aged
(20)
Male
(19)
Aged
(18)
Pharmacology. Drug Treatments
(18)
Adult
(17)
Antineoplastic Agents
(16)
Chemotherapy
(12)
Antineoplastic Agents - Therapeutic Use
(8)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Drug Evaluation
(7)
Neoplasms - Drug Therapy
(7)
Animals
(6)
Antineoplastic Agents - Adverse Effects
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Gallbladder Carcinoma, the Difficulty of Early Detection: A Case Report

The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis

Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer

Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors

AE37: a novel T-cell-eliciting vaccine for breast cancer

Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neck

The significance of circulating epithelial cells in Breast Cancer patients by a novel negative selection method

Interleukin 2 gene transfer prevents NKG2D suppression and enhances antitumor efficacy in combination with cisplatin for head and neck squamous cell cancer

New recurrent balanced translocations in acute myeloid leukemia and myelodysplastic syndromes: Cancer and leukemia group B 8461

Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib

Phase I Trial of All-Trans Retinoic Acid in Patients with Treated Head and Neck Squamous Carcinoma

Prospective validation of a pharmacologically based dosing scheme for the cis-diamminedichloroplatinum(II) analogue diamminecyclobutanedicarboxylatoplatinum

Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors

Neoadjuvant chemoradiation to convert locally advanced pancreatic body adenocarcinoma to resectable disease

Phase I Trial of Granulocyte—Macrophage Colony-Stimulating Factor Plus High-Dose Cyclophosphamide Given Every 2 Weeks: a Cancer and Leukemia Group B Study

A limited sampling strategy for cyclophosphamide pharmacokinetics

Phase I clinical and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered as a five-day continuous infusion

Gram-negative multidrug-resistant organism colonization in a US military healthcare facility in Iraq

Phase I trial using adaptive control dosing of hexamethylene bisacetamide (NSC 95580)

Human pharmacokinetics, excretion, and metabolism of the anthracycline antibiotic menogaril (7-OMEN, NSC 269148) and their correlation with clinical toxicities

Biomarker correlation to clinical response in phase I/II trials of the adjuvant breast cancer vaccine neuvax (nelipepimut-S or E75)

Phase I study and pharmacokinetics of menogaril (NSC 269148) in patients with hepatic dysfunction

Abstract LB-413: Circulating regulatory T cells (CD4+CD25high CD127low) decrease in breast cancer patients after vaccination with a modified HER-2/ neu HLA class II peptide (AE37) vaccine

Abstract LB-414: Comparison of in vitro and in vivo immunologic responses in a prospective, randomized, single-blinded phase II trial evaluating the HER-2/ neu peptide vaccines GP2 and AE37 in breast cancer patients

Combination nonviral interleukin 2 gene therapy and external-beam radiation therapy for head and neck cancer

Aktive Filter

Suchergebnisse filtern